Bookmark

Add to MyYahoo RSS

Hepatitis News

News on Hepatitis continually updated from thousands of sources around the net.

9 hrs ago | CiteULike

Hepatitis C virus itself is a causal risk factor for chronic kidney...

Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.

Comment?

Related Topix: Medicine, Health

Sat Apr 19, 2014

Examiner.com

Keeping Your Liver Healthy

The liver is one of the hardest working organs in your body. It literally works all the time without taking a break to perform several essential functions in the body.

Comment?

Related Topix: Medicine, Health, Nutrition

US Pharmacist

Hepatitis C Still a Challenge for HIV Patients

A study led by researchers at the Perelman School of Medicine at the University of Pennsylvania has found that the risk of hepatitis C-associated serious liver disease persists in patients with HIV otherwise benefitting from antiretroviral therapy .

Comment?

Related Topix: Medicine, Health, University of Pennsylvania

South China Morning Post

In debate on price of new medicines, a middle ground needs finding

An announcement of a cure for a disease that affects millions across the globe is naturally greeted with relief and enthusiasm.

Comment?

Related Topix: Biotech, Gilead Sciences, Medicine, Healthcare Industry, Health

Bellingham Herald

Oklahoma dental groups oppose oral surgery measure

The Tulsa World reports that the bill would set forth the training required to obtain a permit as an oral surgery dental assistant.

Comment?

Related Topix: Dentistry, Medicine, Health

Investor's Business Daily

Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

Can biotech stocks bounce back? As recently as last month, the Medical-Biomed/Biotech group was ranked No.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Financial Markets, Health

Northern Michigan News

Flood waters could carry health risks

The record flooding in our area may carry a hidden danger - the threat of waterborne infections.

Comment?

Related Topix: Medicine, Health

US Pharmacist

Hepatitis C Alert: Baby Boomers Should Be Tested

In the United States, an estimated 3.2 million people are living with chronic hepatitis C virus infection, the potentially fatal liver disease.1 While anyone can get HCV, more than 75% of these are baby boomers - the generation born between 1945 and 1965.2 In 75% to 85% of persons initially infected with HCV, the disease becomes chronic; ... (more)

Comment?

Related Topix: Medicine, Health, Centers for Disease Control and Prevention

Fri Apr 18, 2014

Lake Cowichan Gazette

Giving the gift of life

Port Alberni resident Maryann Rumney wants people to know that you don't have to wait until after you're dead to donate an organ to save someone.

Comment?

Related Topix: Canada, Health,

US Pharmacist

Management of Hepatitis C Genotype 1 Monoinfection

ABSTRACT: Hepatitis C is a common cause of end-stage liver disease in the United States.

Comment?

Related Topix: Medicine

SBWire

"Comvax (Prophylactic Hepatitis B Virus Vaccines) - Forecast and...

Hepatitis B, which is caused by the hepatitis B virus , is characterized by acute or chronic inflammation of the liver.

Comment?

Related Topix: Medicine, Health, Vaccinations

Food Quality News

Recalls: Hepatitis A, E.coli, glass and allergens

This week in the recall round-up gallery the reasons behind food withdrawals takes us to Norway, Belgium, Germany, the UK, USA, Canada and Australia.

Comment?

Related Topix: Medicine, Health

Medical News Today

Mechanism helps explain persistence of hepatitis C virus

For your information: MNT accounts were not affected by the recent Heartbleed bug, as we were not running a vulnerable version of OpenSSL.

Comment?

Related Topix: Medicine, UC San Diego

Thu Apr 17, 2014

Reuters

England agrees funding for Gilead hepatitis C drug

Health authorities in England have approved an 18.7 million pound investment to provide Gilead Sciences' controversial new hepatitis C pill Sovaldi for seriously ill patients.

Comment?

Related Topix: Biotech, Gilead Sciences, Medicine, Healthcare Industry, Health

The Daily Star

How Hepatitis C can help Egypt's regime

A friend who is an epidemiologist called the other day: "Hey Maria, did you know you're living in the middle of an epidemic?" he asked.

Comment?

Related Topix: World News, Africa, Egypt, Epidemic, Natural Disasters, Nursing, Opinion

The American Journal of Managed Care

Recent Trends in the Treatment of Chronic Hepatitis C

Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS Since the discovery of the hepatitis C virus in 1989, the chronically infected population has experienced dynamic change.

Comment?

Related Topix: Medicine, Health

Aidsmap

Sofosbuvir + new GS-5816 NS5A inhibitor is effective against hepatitis C genotypes 1-6

Our award-winning series of patient information booklets. Each title provides a comprehensive overview of one aspect of living with HIV.

Comment?

Related Topix: Health

AlertNet

UnitedHealth: New hepatitis C drug costs far more than forecast

UnitedHealth Group Inc, the largest U.S. health insurer, said on Thursday it has spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc, a higher cost than it expected by "multiples," sending shares in the sector lower.

Comment?

Related Topix: Beverages, United Group, Medicine, Health, Biotech, Gilead Sciences, Healthcare Industry, Aetna, Insurance, Healthcare Law, Law, Medicare

Science Blog

Deaths from viral hepatitis surpass HIV/AIDS in many countries

Deaths from viral Hepatitis B and C have surpassed HIV/AIDS in many countries, including Australia and in Western Europe, according to an analysis of the 2010 Global Burden of Disease study.

Comment?

Related Topix: Medicine, Health, Liver Cancer

HIV and Hepatitis

EASL 2014: BMS Dual Combo Cures 90% of Genotype 1b Hepatitis C in 24 Weeks

A combination of 2 direct-acting antivirals developed by Bristol-Myers Squibb , daclatasvir and asunaprevir, cured 90% of previously untreated people with genotype 1b hepatitis C in 24 weeks, without the need for pegylated interferon or ribavirin, Michael Manns of Hannover Medical School reported at the 49thEASL International Liver Congress in ... (more)

Comment?

Related Topix: Medicine, Health, Biotech, Bristol Myers Squibb, Healthcare Industry, Genetics

•••
•••
•••
•••
•••
•••
•••
•••
•••